Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

53.79%

Threshold

Crossed downwards

Timeline

Published

17.04.2020

Transaction

07.04.2020

Voting rights breakdown

Voting rights acquired10.77%
Voting rights sold53.79%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAK4F00068

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

Erwerb und Veräusserung von Aktien am 8. April 2020

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open